WO 2016/176146 Al 3 November 2016 (03.11.2016) P O P C T

Total Page:16

File Type:pdf, Size:1020Kb

WO 2016/176146 Al 3 November 2016 (03.11.2016) P O P C T (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/176146 Al 3 November 2016 (03.11.2016) P O P C T (51) International Patent Classification: (74) Agent: WALES, Michele M. 118 16 Centurion Way, Po- A01N 25/08 (2006.01) A01N 43/647 (2006.01) tomac, Maryland 20854 (US). A 25/10 (2006.01) A01P 1/00 (2006.01) (81) Designated States (unless otherwise indicated, for every (21) International Application Number: kind of national protection available): AE, AG, AL, AM, PCT/US20 16/0292 13 AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (22) International Filing Date: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, 25 April 2016 (25.04.2016) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (25) Filing Language: English KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (26) Publication Language: English PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (30) Priority Data: SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 62/152,896 26 April 2015 (26.04.2015) US TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant: THE TRUSTEES OF PRINCETON UNI¬ (84) Designated States (unless otherwise indicated, for every VERSITY [US/US]; 87 Prospect Avenue, 3rd Floor, Prin kind of regional protection available): ARIPO (BW, GH, ceton, New Jersey 08544 (US). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (72) Inventors: BASSLER, Bonnie L.; 39 Pine Street, Prin TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, ceton, New Jersey 08540 (US). STONE, Howard A.; 94 DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, McCosh Circle, Princeton, New Jersey 08540 (US). KIM, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, Min Young; 15 1 Taylor Court, Room 212, Princeton, New SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, Jersey 08540 (US). MUIR, Thomas William; 35 Lit- GW, KM, ML, MR, NE, SN, TD, TG). tlebrook Road, N, Princeton, New Jersey 08540 (US). Published: ZHAO, Aishan; 2 Lawrence Drive, Apt. 104, Princeton, New Jersey 08540 (US). — with international search report (Art. 21(3)) (54) Title: SURFACES COMPRISING ATTACHED QUORUM SENSING MODULATORS (57) Abstract: The invention relates to compositions comprising QS modulating molecules attached to a surface via a linker. This QS modulator attached surface can then be used to modulate QS, biofilm production, biofilm streamer production and/or virulence factor production. These QS modulator attached surfaces can be used to treat areas known to contain human pathogens notorious for causing hospital-acquired infections as well as fatal infections that occur outside of health care settings. Other surfaces that can be coated according to embodiments of the invention include abiotic materials, such as intravenous catheters, implants, medical devices, and cooling towers. Preferred microorganisms that can be treated with the compositions of the invention include, but are not limited to S. aureus and/or P. aeruginosa. SURFACES COMPRISING ATTACHED QUORUM SENSING MODULATORS STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT [0001] This invention was made with government support under Grant No MCB-1 119232, Grant No. MCB-1344191 and Grant No. MCB-09481 12 awarded by the National Science Foundation and Grant No. GM- 065859 awarded by the National Institutes of Health. The government may have certain rights in the invention. BACKGROUND [0002] In a process referred to as quorum sensing, microorganisms, such as bacteria, communicate using chemical signaling molecules called autoinducers. By monitoring increases and decreases in autoinducer concentration, quorum-sensing bacteria track changes in cell-population density and synchronously switch into and out of group behaviors. Quorum sensing allows bacteria to collectively carry out tasks that would be unsuccessful if carried out by an individual bacterium acting alone. [0003] Both Gram-positive and Gram-negative infectious bacteria, which include human, animal, plant, and marine pathogens, use quorum-sensing strategies to control virulence. Quorum sensing also controls biofilm and streamer formation. Biofilms are communities of bacterial cells adhered to surfaces and encased in a self-excreted matrix of extracellular polymeric substances. In most environments, bacteria are found predominantly in biofilms. These biofilms are also widespread in industrial systems and are associated with increased risk of infection when found in clinical environments and in indwelling medical devices. These bacterial biofilm communities can cause chronic infections in humans by colonizing, for example, in medical implants, heart valves, or lungs. [0004] In settings involving fluid flow across the biofilm, as in rivers or in industrial and medical systems that are subject to flow, filamentous biofilms, called streamers, can be formed. These streamers can have a dramatic effect on the biofilm environment. In rivers, for example, the biofilm streamers can increase transient storage and cycling of nutrients and can enhance the retention of suspended particles. In industrial and medical settings, the biofilm streamers have been associated with increased issues associated with clogging and pressure drops. [0005] Bacterial infections are treated with bactericidal or bacteriostatic molecules that impede at least five major processes: cell wall formation, DNA replication, transcription, translation or tetrahydrofolic acid synthesis. Existing methods for treating bacterial infection unfortunately exacerbate the growing antibiotic resistance problem because they inherently select for growth of bacteria that can resist the drug. [0006] For example, Staphylococcus aureus is a human pathogen notorious for causing hospital-acquired infections as well as fatal infections that occur outside of health care settings. S. aureus infections that are associated with abiotic materials, such as intravenous catheters and implants, are of primary concern as S. aureus readily colonizes such medical devices, forming biofilms, biofilm streamers and initiates virulence factor production under these conditions. [0007] In fact, methicillin-resistant S. aureus (MRSA) is a major concern due to its potent virulence coupled with resistance to many antibiotics. MRSA is the most widespread cause of hospital-associated infections in the United States and Europe with a high mortality rate. S. aureus and MRSA cause a variety of infections ranging from minor skin infections to serious illnesses such as infections of indwelling medical devices, osteomyelitis, endocarditis, sepsis, and toxic shock syndrome. S. aureus is just one example of a microorganism that uses quorum-sensing-mediated communication to control virulence factor production and to regulate biofilm formation. [0008] Thus, what is needed are new methods of modulating quorum sensing, biofilm formation, biofilm streamer formation, and/or virulence factor production from microorganisms. SUMMARY [0009] This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject. [0010] The present invention targets the quorum sensing ("QS") systems utilized by microorganisms, which are crucial in microorganism infection and pathogenicity. This technology is the first to describe and successfully conjugate QS modulating molecules (either QS antagonists or agonists) to a surface and show alterations in QS-controlled phenotypes. Preferred examples of altered QS phenotypes (also referred to as traits) include, but are not limited to, significant reductions in biofilm formation, biofilm streamer formation and virulence factor production. This technology can be immediately applied to many current and urgent issues in healthcare settings, such as the accidental introduction of pathogens into patients during medical procedures and the entry of bacteria at wound sites. This technology can be used to modify existing (e.g., medical, food processing, agricultural, etc.) devices, create new devices, and it could also be applied as a direct treatment for patients. Beyond medicine, this technology can also be applied to fields including, but not limited to, industrial and engineering processes, food processing, cooling towers, and mining. [0011] Thus, the present invention relates to a method of modulating QS, biofilm production, biofilm streamer production, and/or virulence factor production by a microorganism using: (1) an antagonist to decrease QS, or (2) an agonist to increase QS, wherein the QS modulator is attached to a surface through a linker. A microorganism that is exposed to the surface will exhibit altered biofilm production, biofilm streamer production, and/or virulence factor production. In some embodiments, inhibiting QS will lead to a decrease in biofilm production, biofilm streamer production, and/or virulence factor production. In other embodiments, agonizing QS will lead to a decrease in biofilm production, biofilm streamer production, and/or virulence factor production. [0012] For example, a QS modulator molecule attached to a surface can be used
Recommended publications
  • Lpr0050 and Lpr0024 in Legionella Pneumophila
    Characterization of the role of the small regulatory RNA (sRNAs) lpr0050 and lpr0024 in Legionella pneumophila Malak Sadek Natural Resource Sciences Department McGill University Montreal, Canada Supervisor: Prof. Sébastien P. Faucher June , 2019 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master of Science © Malak Sadek 2019 1 Abstract Legionella pneumophila is a facultative intracellular pathogen, and it is the causative agent of Legionnaires’ disease, a life-threatening form of pneumonia. L. pneumophila is commonly found in most water systems including freshwater bodies, rivers, and lakes as well as in engineered water systems and man-made water distribution systems such as cooling towers. Free-living amoeba in aquatic environments are the primary reservoir of L. pneumophila. Following inhalation of contaminated water droplets by humans, L. pneumophila infects and replicates within lung alveolar macrophages and potentially causes Legionnaires’ disease (LD) in susceptible individuals. The bacterium establishes its intracellular niche by forming the Legionella-containing vacuoles (LCVs). L. pneumophila governs the formation of the LCV and intracellular growth through the Icm/Dot type IVB secretion system. Icm/Dot is able to translocate around 300 protein effectors in the host cell allowing L. pneumophila to modulate many signalling and metabolic pathways of the host to its benefit. It is believed that Small Regulatory RNAs (sRNAs) are major players of regulation of virulence-related genes in L. pneumophila. We investigated the regulatory role of the two sRNA Lpr0050 and Lpr0024. Lpr0050 is encoded on the complementary strand of the effector SdeA. Using northern blot we showed that the cis-encoded sRNALpr0050 is expressed in the Exponential (E) phase and Post-Exponential (PE) phase in the wild-type, ΔcpxR and ΔletS.
    [Show full text]
  • List of the Pathogens Intended to Be Controlled Under Section 18 B.E
    (Unofficial Translation) NOTIFICATION OF THE MINISTRY OF PUBLIC HEALTH RE: LIST OF THE PATHOGENS INTENDED TO BE CONTROLLED UNDER SECTION 18 B.E. 2561 (2018) By virtue of the provision pursuant to Section 5 paragraph one, Section 6 (1) and Section 18 of Pathogens and Animal Toxins Act, B.E. 2558 (2015), the Minister of Public Health, with the advice of the Pathogens and Animal Toxins Committee, has therefore issued this notification as follows: Clause 1 This notification is called “Notification of the Ministry of Public Health Re: list of the pathogens intended to be controlled under Section 18, B.E. 2561 (2018).” Clause 2 This Notification shall come into force as from the following date of its publication in the Government Gazette. Clause 3 The Notification of Ministry of Public Health Re: list of the pathogens intended to be controlled under Section 18, B.E. 2560 (2017) shall be cancelled. Clause 4 Define the pathogens codes and such codes shall have the following sequences: (1) English alphabets that used for indicating the type of pathogens are as follows: B stands for Bacteria F stands for fungus V stands for Virus P stands for Parasites T stands for Biological substances that are not Prion R stands for Prion (2) Pathogen risk group (3) Number indicating the sequence of each type of pathogens Clause 5 Pathogens intended to be controlled under Section 18, shall proceed as follows: (1) In the case of being the pathogens that are utilized and subjected to other law, such law shall be complied. (2) Apart from (1), the law on pathogens and animal toxin shall be complied.
    [Show full text]
  • Antigenic Heterogeneity Among Legionella, Fluoribacter, and Tatlockia Species Analyzed by Crossed Immunoelectrophoresis
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Oct. 1987, p. 351-356 Vol. 37, No. 4 0020-7713/87/040351-06$02.00/0 Copyright 0 1987, International Union of Microbiological Societies Antigenic Heterogeneity Among Legionella, Fluoribacter, and Tatlockia Species Analyzed by Crossed Immunoelectrophoresis MICHAEL T. COLLINS,l* JETTE M. BANGSBORG,2 AND NIELS H@IBY2 Department of Pathobiological Sciences, University of Wisconsin, Madison, Wisconsin 53706’ and State Serum Institute, Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark2 Crossed immunoelectrophoresis (XIE) reference systems were established for Fluoribacter (Legionella) (containing Fluoribacter bozemanae, Fluoribacter dumofii, and Fluoribacter gormanii) and for Tatlockia (Legionella) micdadei. The Fluoribacter and Tatlockia XIE reference systems contained 54 and 72 anode- migrating antigens, respectively. These two systems, together with the previously described polyvalent Legionella pneumophila (serogroups 1 through 6) XIE reference system, were used to study the cross- reactivities of antigens from organisms comprising the three proposed genera in the family Legionellaceae. Antigenic homology was expressed as the matching coefficient (MC), the ratio of the number of cross-reactive antigens to the total number of antigens. The MCs for individual L. pneumophila serogroups when the polyvalent L. pneumophila antibody was used were 0.98 f 0.05, which was significantly higher than the MCs determined by using Fluoribacter or Tatlockia antibodies (0.50 f 0.13) (P < 0.001). The MCs for the three species of Fluoribacter when polyvalent Fluoribacter antibody was used were 0.93 & 0.10, which was also significantly higher than the MCs when heterologous antibodies were used (0.40 f 0.04) (P< 0.001). The MCs for T.
    [Show full text]
  • Pesnyakevich.Pdf
    щ УДК 579.61(075.8)+579.63(075.8) ББК 52.64я73+51.201.7я73 П28 Рецензенты: кафедра биотехнологии и биоэкологии Белорусского государственного технологическго университета (заведующий кафедрой кандидат химических наук, доцент В. Н. Леонтьев); кандидат биологических наук, доцент Н. А. Белясова; кандидат биологических наук, доцент Л. Н. Валентович Песнякевич, А. Г. П28 Медицинская и санитарная микробиология : учеб. пособие / А. Г. Пес- някевич. – Минск, 2017. – 231 с. ISBN 978-985-566-452-0. Рассматриваются инфекционный процесс как взаимодействие патогена и ор- ганизма-хозяина, патогенность и вирулентность как общие свойства возбудите- лей инфекционных заболеваний, факторы патогенности и вирулентности болезне- творных бактерий и их действие на клеточно-молекулярном уровне. Описываются общие принципы борьбы с инфекционными заболеваниями, а также основы про- филактики и терапии инфекционных болезней. Приводятся современные сведения о систематическом положении возбудителей инфекционных заболеваний бактери- альной этиологии и вызываемых ими инфекционных процессах. Предназначено для студентов, обучающихся в учреждениях высшего образова- ния по специальностям «Биология (по направлениям)», «Микробиология». УДК 579.61(075.8)+579.63(075.8) ББК 52.64я73+51.201.7я73 ISBN 978-985-566-452-0 © Песнякевич А. Г., 2017 © БГУ, 2017 ВВЕДЕНИЕ Предлагаемое учебное пособие написано согласно программе, утверж- денной для студентов биологического факультета Белорусского государ- ственного университета. По этой причине в книге отсутствуют общие све дения о строении, физиологии и экологии микроорганизмов, а также о строении и функционировании иммунной системы млекопитающих, уже известные студентам пятого года обучения из общих курсов «Ми- кробиология» и «Основы иммунологии». Кроме того, в разделе «Частная медицинская микробиология» рассматриваются только бактериальные возбудители инфекционных заболеваний человека, поскольку о па тоген- ных грибах и вирусах студенты биофака БГУ узнают из других курсов, читаемых на факультете.
    [Show full text]
  • The Role of Lipids in Legionella-Host Interaction
    International Journal of Molecular Sciences Review The Role of Lipids in Legionella-Host Interaction Bozena Kowalczyk, Elzbieta Chmiel and Marta Palusinska-Szysz * Department of Genetics and Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; [email protected] (B.K.); [email protected] (E.C.) * Correspondence: [email protected] Abstract: Legionella are Gram-stain-negative rods associated with water environments: either nat- ural or man-made systems. The inhalation of aerosols containing Legionella bacteria leads to the development of a severe pneumonia termed Legionnaires’ disease. To establish an infection, these bacteria adapt to growth in the hostile environment of the host through the unusual structures of macromolecules that build the cell surface. The outer membrane of the cell envelope is a lipid bilayer with an asymmetric composition mostly of phospholipids in the inner leaflet and lipopolysaccha- rides (LPS) in the outer leaflet. The major membrane-forming phospholipid of Legionella spp. is phosphatidylcholine (PC)—a typical eukaryotic glycerophospholipid. PC synthesis in Legionella cells occurs via two independent pathways: the N-methylation (Pmt) pathway and the Pcs pathway. The utilisation of exogenous choline by Legionella spp. leads to changes in the composition of lipids and proteins, which influences the physicochemical properties of the cell surface. This phenotypic plastic- ity of the Legionella cell envelope determines the mode of interaction with the macrophages, which results in a decrease in the production of proinflammatory cytokines and modulates the interaction with antimicrobial peptides and proteins. The surface-exposed O-chain of Legionella pneumophila sg1 LPS consisting of a homopolymer of 5-acetamidino-7-acetamido-8-O-acetyl-3,5,7,9-tetradeoxy-L- glycero-D-galacto-non-2-ulosonic acid is probably the first component in contact with the host cell that anchors the bacteria in the host membrane.
    [Show full text]
  • CGM-18-001 Perseus Report Update Bacterial Taxonomy Final Errata
    report Update of the bacterial taxonomy in the classification lists of COGEM July 2018 COGEM Report CGM 2018-04 Patrick L.J. RÜDELSHEIM & Pascale VAN ROOIJ PERSEUS BVBA Ordering information COGEM report No CGM 2018-04 E-mail: [email protected] Phone: +31-30-274 2777 Postal address: Netherlands Commission on Genetic Modification (COGEM), P.O. Box 578, 3720 AN Bilthoven, The Netherlands Internet Download as pdf-file: http://www.cogem.net → publications → research reports When ordering this report (free of charge), please mention title and number. Advisory Committee The authors gratefully acknowledge the members of the Advisory Committee for the valuable discussions and patience. Chair: Prof. dr. J.P.M. van Putten (Chair of the Medical Veterinary subcommittee of COGEM, Utrecht University) Members: Prof. dr. J.E. Degener (Member of the Medical Veterinary subcommittee of COGEM, University Medical Centre Groningen) Prof. dr. ir. J.D. van Elsas (Member of the Agriculture subcommittee of COGEM, University of Groningen) Dr. Lisette van der Knaap (COGEM-secretariat) Astrid Schulting (COGEM-secretariat) Disclaimer This report was commissioned by COGEM. The contents of this publication are the sole responsibility of the authors and may in no way be taken to represent the views of COGEM. Dit rapport is samengesteld in opdracht van de COGEM. De meningen die in het rapport worden weergegeven, zijn die van de auteurs en weerspiegelen niet noodzakelijkerwijs de mening van de COGEM. 2 | 24 Foreword COGEM advises the Dutch government on classifications of bacteria, and publishes listings of pathogenic and non-pathogenic bacteria that are updated regularly. These lists of bacteria originate from 2011, when COGEM petitioned a research project to evaluate the classifications of bacteria in the former GMO regulation and to supplement this list with bacteria that have been classified by other governmental organizations.
    [Show full text]
  • Identification Et Caractérisation De Composés Produits Par Des Bactéries Environnementales Pour La Lutte Biologique Contre Legionella Pneumophila Marie-Hélène Corre
    Identification et caractérisation de composés produits par des bactéries environnementales pour la lutte biologique contre Legionella pneumophila Marie-Hélène Corre To cite this version: Marie-Hélène Corre. Identification et caractérisation de composés produits par des bactéries environ- nementales pour la lutte biologique contre Legionella pneumophila. Chimie analytique. Université de Poitiers, 2018. Français. NNT : 2018POIT2309. tel-02461235 HAL Id: tel-02461235 https://tel.archives-ouvertes.fr/tel-02461235 Submitted on 30 Jan 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THESE Pour l’obtention du Grade de DOCTEUR DE L’UNIVERSITE DE POITIERS FACULTE DES SCIENCES FONDAMENTALES ET APPLIQUEES (Diplôme National - Arrêté du 25 mai 2016) Ecole Doctorale : Gay Lussac – Sciences pour l'environnement Secteur de Recherche : Aspects moléculaires et cellulaires de la biologie - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Identification et caractérisation de composés produits par des
    [Show full text]
  • Legionella and Non-Tuberculous Mycobacteria Using MALDI TOF MS (Matrix Assisted Laser Desorption Ionisation Time of Flight Mass Spectrometry)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by OTHES DIPLOMARBEIT Titel der Diplomarbeit Establishment of a reference database for Acanthamoeba, Legionella and non-tuberculous mycobacteria using MALDI TOF MS (Matrix Assisted Laser Desorption Ionisation Time of Flight Mass Spectrometry) Verfasserin Dzenita HASANACEVIC angestrebter akademischer Grad Magistra der Naturwissenschaften (Mag.rer.nat.) Wien, 2012 Studienkennzahl lt. A 442 Studienblatt: Studienrichtung lt. Studienblatt: Anthropologie Betreuerin: Ass. Prof. Univ. Doz. Mag. Dr. Julia Walochnik Contents 1 ABBREVIATIONS ..................................................................................................... 5 2 INTRODUCTION ....................................................................................................... 6 2.1 Acanthamoeba .................................................................................................... 6 2.1.1 Classification ................................................................................................ 6 2.1.1.1 Phylogeny of Acanthamoeba ................................................................. 6 2.1.1.2 Methods of classification ....................................................................... 8 2.1.2 Ecology and geographical distribution ........................................................ 11 2.1.2.1 Life cycle ............................................................................................. 11 2.1.2.2 Trophozoites ......................................................................................
    [Show full text]
  • Methods Development for Unregulated Contaminants in Drinking Water
    Method Development for Unregulated Contaminants in Drinking Water: Public Meeting and Webinar Held June 6, 2018 USEPA, Office of Ground Water and Drinking Water Office of Water (MLK 140) EPA 815-A-18-001 June 2018 Methods Development for Unregulated Contaminants in Drinking Water Methods Development for Unregulated Contaminants in Drinking Water Public Meeting and Webinar June 6, 2018 9:00 a.m. ‐ 3:00 p.m. ET U.S. EPA Office of Water and Office of Research and Development Welcome & SDWA Regulatory Process Brenda Parris, U.S. EPA Office of Ground Water and Drinking Water Technical Support Center Page 1 of 103 Methods Development for Unregulated Contaminants in Drinking Water Participating by Webinar • Listen‐only mode Figure 1 • Click on “+” next to “Questions” in the control panel (Figure 1) to submit questions/comments Figure 2 • Type a question in the box; click send (Figure 2) • Submit questions as soon as possible • Questions will be answered at the end of the presentations June 2018 U.S. Environmental Protection Agency Slide 3 of 206 Agenda 8:30‐9:00 Stakeholder Sign‐In Welcome & SDWA Regulatory Process Overview of Method Development EPA Method 542 EPA Methods 524.2/524.3/524.4 and 525.3 EPA Method 556.1 ~10:15‐10:30 Break EPA Method 540 & 543 EPA Methods 537 & 538 Method in Development: PFAS Method in Development 558: Ethyl carbamate (Urethane) and N‐Methyl‐2‐pyrrolidone Method in Development: Nonylphenols ~11:45‐12:45 Lunch Method in Development: Legionella Method in Development: Mycobacterium ~1:45‐2:00 Break 2:00‐3:00 Open Forum and Discussion Closing Remarks Page 2 of 103 Methods Development for Unregulated Contaminants in Drinking Water Overview • Regulatory background for UCMR • Safe Drinking Water Act (SDWA) authority • Relationships to: • Contaminant Candidate List (CCL) • Unregulated Contaminant Monitoring Rule (UCMR) • Regulatory Determination • Six‐Year Review June 2018 U.S.
    [Show full text]
  • Water-Borne Infections in Hospitals and Their Prevention - No Water Is Worse Than Still Water
    Water-borne infections in hospitals and their prevention - no water is worse than still water Egil Lingaas Department of Infection Prevention, Oslo University Hospital, Norway Oslo University Hospital Department of Infection Prevention 03/2016 Egil Lingaas Legionella 54 species and 74 antigenic types Widespread in environment in low numbers Water and humid environments Compost Ca. 20 species have caused human infection Most common (> 90 %): Legionella pneumophila Legionella micdadei ca 2 % Legionella bozemanae ca 2 % Int J Syst Evol Microbiol 2010;62:2946 Oslo University Hospital Department of Infection Prevention 03/2016 Egil Lingaas Legionella Replicates at temperatures between 20 and 50 (45) oC Still water increases the risk of growth Water in buildings therefore at increased risk Oslo University Hospital Department of Infection Prevention 03/2016 Egil Lingaas 60 50 40 Publications on Legionella and “hospital” (medline) last 20 years 30 20 Number of publications of Number 10 0 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Oslo University Hospital N = 680 Department of Infection Prevention 03/2016 Egil Lingaas CID 2016:62 (1 February) • 273 Oslo University Hospital Department of Infection Prevention 03/2016 Egil Lingaas There are reasons to believe that Legionella is a small problem compared to other water-borne infections in hospitals Oslo University Hospital Department of Infection Prevention 03/2016 Egil Lingaas Rutala WA: Infect Control Hosp Epidemiol 1997;1:609 Oslo
    [Show full text]
  • Antigenic Heterogeneity Among Legionella, Fluoribacter, and Tatlockia Species Analyzed by Crossed Immunoelectrophoresis
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Oct. 1987, p. 351-356 Vol. 37, No. 4 0020-7713/87/040351-06$02.00/0 Copyright 0 1987, International Union of Microbiological Societies Antigenic Heterogeneity Among Legionella, Fluoribacter, and Tatlockia Species Analyzed by Crossed Immunoelectrophoresis MICHAEL T. COLLINS,l* JETTE M. BANGSBORG,2 AND NIELS H@IBY2 Department of Pathobiological Sciences, University of Wisconsin, Madison, Wisconsin 53706’ and State Serum Institute, Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark2 Crossed immunoelectrophoresis (XIE) reference systems were established for Fluoribacter (Legionella) (containing Fluoribacter bozemanae, Fluoribacter dumofii, and Fluoribacter gormanii) and for Tatlockia (Legionella) micdadei. The Fluoribacter and Tatlockia XIE reference systems contained 54 and 72 anode- migrating antigens, respectively. These two systems, together with the previously described polyvalent Legionella pneumophila (serogroups 1 through 6) XIE reference system, were used to study the cross- reactivities of antigens from organisms comprising the three proposed genera in the family Legionellaceae. Antigenic homology was expressed as the matching coefficient (MC), the ratio of the number of cross-reactive antigens to the total number of antigens. The MCs for individual L. pneumophila serogroups when the polyvalent L. pneumophila antibody was used were 0.98 f 0.05, which was significantly higher than the MCs determined by using Fluoribacter or Tatlockia antibodies (0.50 f 0.13) (P < 0.001). The MCs for the three species of Fluoribacter when polyvalent Fluoribacter antibody was used were 0.93 & 0.10, which was also significantly higher than the MCs when heterologous antibodies were used (0.40 f 0.04) (P< 0.001). The MCs for T.
    [Show full text]
  • Agglutinating Antibody Titers to Members of the Family Reacting Antibodies to Pseudomonas Aeruginosa
    JOURNAL OF CLINICAL MICROBIOLOGY, June 1984, P. 757-762 Vol. 19, No. 6 0095-1137/84/060757-06$02.00/0 Copyright C 1984, American Society for Microbiology Agglutinating Antibody Titers to Members of the Family Legionellaceae in Cystic Fibrosis Patients as a Result of Cross- Reacting Antibodies to Pseudomonas aeruginosa MICHAEL T. COLLINS,lt* JEANNETTE McDONALD, NIELS H0IBY,2 AND OLE AALUND3 Department of Microbiology and Environmental Health, Colorado State University, Fort Collins, Colorado 805231; and Statens Seruminstitut, Department of Clinical Microbiology, and Pediatric Department TG, Rigshospitalet,2 and Laboratory of Preventive Medicine, Royal Veterinary and Agriculture College,3 Copenhagen, Denmark Received 6 October 1983/Accepted 9 March 1984 The objective of this study was to evaluate the prevalence and significance of antibody titers to organisms in the family Legionellaceae in 128 serum samples collected from cystic fibrosis patients at routine examinations. Antibody titers were determined for 10 antigenic types of Legionellaceae; Legionella pneumophila serogroups 1 to 6, Fluoribacter (Legionella) bozemanae, Fluoribacter (Legionella) dumoffii, Fluoribacter (Legionella) gormanii, and Tatlockia (Legionella) micdadei. The method of antibody titer determination was the microagglutination test. Elevated titers (.1:64) to one or more antigens were found in 41.3% of cystic fibrosis patients but in only 9.7% of 103 normal control subjects (P < 0.01). Titers to 8 of the 10 antigens were directly correlated with the number ofPseudomonas aeruginosa precipitating antibodies in patient sera, as determined by crossed immunoelectrophoresis (correlation coefficients, -0.74). Cross- reactions between P. aeruginosa and L. pneumophila were substantiated by crossed immunoelectrophore- sis of hyperimmune rabbit serum as well as patient sera against P.
    [Show full text]